Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-111566
Filing Date
2024-12-23
Accepted
2024-12-23 09:25:28
Documents
1
Period of Report
2024-12-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4294
  Complete submission text file 0001213900-24-111566.txt   5674
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3 MURRAY HILL ROAD SCARSDALE NY 10583
Business Address
Lemerond Nicole (Reporting) CIK: 0001941712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39685 | Film No.: 241570344